Sixty-ninth World Health Assembly

KEI/HAI Interventions HAI/KEI intervention at the WHA69 on the Framework of Engagement with Non-State Actors HAI/KEI intervention at the WHA69 on the negotiations on an R&D agreement Interventions by Member States WHA 69: Colombian Minister of Health Calls on WHO… Continue Reading

Seventieth World Health Assembly

Interventions made by KEI WHA70: Statement of Knowledge Ecology International – CEWG follow up WHA70: Statement of Knowledge Ecology International on antimicrobial resistance WHA70: Statement of Knowledge Ecology International on review of the GSPOA-PHI WHA70: Statement of Knowledge Ecology International:… Continue Reading

Seventy-first World Health Assembly

Interventions made by KEI WHA71: KEI statement on the Draft thirteenth general programme of work, 2019–2023 WHA71: KEI intervention on the Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to… Continue Reading

WHO donors in 2017 – US, Gates Foundation, UK, World Bank, GAVI, Germany and the European Commission: Setting the Agenda for Global Health?

In advance of the 71st World Health Assembly (21 May 2018 – 26 May 2018), the World Health Organization (WHO) published a document (A71/INF./2, 19 April 2018) entitled, Voluntary contributions by fund and by contributor, 2017. Total voluntary contributions to… Continue Reading

NIH response to KEI request for NIH policy on on the licensing of federally-funded CRISPR patented inventions.

On June 6, 2017, KEI wrote to Dr. Thomas Price, Secretary of Health and Human Services (HHS), and Dr. Francis S. Collins, Director of the National Institutes of Health (NIH) requesting the HHS develop a policy on the licensing of federally-funded CRISPR patented inventions. A copy of our letter is available here: /node/2801.

Continue Reading

EB 136 Draft decision passed on the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property

On Tuesday February 3, 2015, the final day of the 136th WHO Executive Board meeting, the EB passed a draft decision on the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPoA). The draft decision recommends to the WHA that the GSPOA be extended until 2022. Continue Reading

EB 136 Friday, January 30th: Discussion of Consultative Expert Working Group on Research Development-Financing and Coordination

Another matter considered during the Friday, January 30th session of the WHO Executive Board was the “Follow-up of the report on the Consultative Expert Working Group on Research Development-Financing and Coordination.” In addition to the general report on the CEWG, the EB also considered the Director General’s report on the CEWG “Health research and development demonstration projects.”

Continue Reading

EB 136 Friday, January 30th: Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property

On Friday, January 30th, the WHO Executive Board discussed the Global Strategy and Plan of Action on Public Health, Innovation, and Intellectual Property (GSPA). The discussion covered several documents in relation to the GSPoA, including: